Clairette

Clairette is a combined oral contraceptive containing Cyproterone Acetate and Ethinylestradiol. It is used for birth control and managing hormonal acne. This medication is manufactured by Stragen UK Ltd. and is suitable for oral use.

Clairette is primarily used as a contraceptive to prevent pregnancy. It works by inhibiting ovulation and altering the cervical mucus to prevent sperm from reaching the egg. Additionally, Clairette is often prescribed for managing hormonal acne in women, helping to reduce breakouts and improve skin clarity. The combination of Cyproterone Acetate and Ethinylestradiol in Clairette makes it effective for these purposes.

Common effects of Clairette may include changes in menstrual bleeding patterns, such as lighter or more regular periods. Some users may experience breast tenderness, headaches, or mild nausea. These effects are generally mild and temporary. If any severe or persistent effects occur, it is important to consult a healthcare professional.

Clairette should be used with caution in individuals with a history of blood clots, liver disease, or certain types of cancer. It is important to inform your healthcare provider about any pre-existing conditions or medications you are taking. Regular monitoring may be required to ensure the safe use of Clairette.

Clairette may interact with certain medications, including those that induce or inhibit liver enzymes, such as some antibiotics and anticonvulsants. Alcohol consumption should be moderated, as it can affect the effectiveness of the medication. Always consult a healthcare professional before starting or stopping any medication while using Clairette.